Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Leases: 2019-2025

Historic Leases for Fortress Biotech (FBIO) over the last 7 years, with Sep 2025 value amounting to $12.3 million.

  • Fortress Biotech's Leases fell 12.94% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year decrease of 12.94%. This contributed to the annual value of $13.9 million for FY2024, which is 18.42% down from last year.
  • Per Fortress Biotech's latest filing, its Leases stood at $12.3 million for Q3 2025, which was down 3.87% from $12.8 million recorded in Q2 2025.
  • Fortress Biotech's Leases' 5-year high stood at $20.1 million during Q1 2021, with a 5-year trough of $12.3 million in Q3 2025.
  • Moreover, its 3-year median value for Leases was $14.6 million (2024), whereas its average is $15.4 million.
  • In the last 5 years, Fortress Biotech's Leases grew by 5.19% in 2022 and then dropped by 19.19% in 2025.
  • Over the past 5 years, Fortress Biotech's Leases (Quarterly) stood at $19.0 million in 2021, then grew by 5.19% to $20.0 million in 2022, then declined by 15.01% to $17.0 million in 2023, then declined by 18.42% to $13.9 million in 2024, then decreased by 12.94% to $12.3 million in 2025.
  • Its Leases was $12.3 million in Q3 2025, compared to $12.8 million in Q2 2025 and $13.3 million in Q1 2025.